Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
Baral, R.; White, M.; Vassiliou, V. S.
Show abstract
Inhibitors of the Renin-Angiotensin-Aldosterone System (RAAS) notably Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB) have been scrutinised in hypertensive patients hospitalised with coronavirus disease 2019 (COVID-19) following some initial data they might adversely affect prognosis. With an increasing number of COVID-19 cases worldwide and the likelihood of a "second wave" of infection it is imperative to better understand the impact RAAS inhibitor use in antihypertensive covid positive hospitalised patients. A systematic review and meta-analysis of ACEi or ARB in patients admitted with COVID-19 was conducted. PubMed and Embase were searched and six studies were included in the meta-analysis. Pooled analysis demonstrated that 18.3% of the patients admitted with COVID-19 were prescribed ACEi/ARBs (0.183, CI 0.129 to 0.238, p<0.001). The use of RAAS inhibitors did not show any association with critical events (Pooled OR 0.833 CI 0.605 to 1.148, p=0.264) or death (Pooled OR 0.650, CI 0.356 to 1.187, p=0.161). In conclusion, our meta-analysis including critical events and mortality data on patients prescribed ACEi/ARB and hospitalised with COVID-19, found no evidence to associate ACEi/ARB with death or adverse events.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effectiveness of An Impedance Cardiography Guided Treatment Strategy to Improve Blood Pressure Control in A Real-World Setting: Results from A Pilot Pragmatic Clinical Trial 93%
- Vascular Comorbidities Worsen Prognosis of Patients with Heart Failure Hospitalized with COVID-19 92%
- Effect of a mobile health intervention optimised with artificial intelligence on blood pressure and other cardiovascular risk factors in adults with high blood pressure: Rationale and design of My Intelligent Cardiac Assistant (MICArdiac) Randomised Controlled Trial 92%
Similar papers in this journal
- A systematic review and meta-analysis on the effectiveness of an early invasive strategy compared to a conservative approach in elderly patients with non-ST elevation acute coronary syndrome 93%
- Attrition and associated factors among patients on chronic antihypertensive therapy at Mulago hospital, Uganda: A mixed method study 93%
- Comparison of WHO laboratory-based and non-laboratory-based CVD risk Charts among Hypertensive Adults Attending Primary Healthcare Centers in West Africa Sub-region 93%
Similar papers in this journal
- Impact of Losartan on Portal hypertension and Liver Cirrhosis: A Systematic Review 93%
- Hospitalist perspectives of available tests to monitor volume status in patients with heart failure: a qualitative study 92%
- Comparison of in-hospital mortality and clinical outcomes among patients greater than and less than 80 years undergoing TAVR 91%
Similar papers in this journal
- Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 94%
- The Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction 92%
- High burden of non-adherence to blood pressure-lowering medications: meta-analysis of data from over 34,000 adults with hypertension in Sub-Saharan Africa 92%
Similar papers in this journal
- Antihypertensive Medications and COVID-19 Diagnosis and Mortality: Population-based Case-Control Analysis in the United Kingdom 94%
- Medication adherence and hospitalizations in older patients with coronary heart disease in Vietnam 90%
- A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.